Cysteinyl Leukotriene R1/CysLTR1: Small Molecules and Peptides
The cysteinyl leukotrienes LTC4, LTD4, and LTE4 are important mediators of human bronchial asthma. Pharmacologic studies have determined that cysteinyl leukotrienes activate at least 2 receptors, CysLTR1 and CysLTR2. Both receptors are members of the superfamily of G protein-coupled receptors. Activation of CysLTR1 by LTD4 results in contraction and proliferation of smooth muscle, oedema, eosinophil migration and damage to the mucus layer in the lung.
1 result for "Cysteinyl Leukotriene R1/CysLTR1 Small Molecules and Peptides" in Products
1 result for "Cysteinyl Leukotriene R1/CysLTR1 Small Molecules and Peptides" in Products
Cysteinyl Leukotriene R1/CysLTR1: Small Molecules and Peptides
The cysteinyl leukotrienes LTC4, LTD4, and LTE4 are important mediators of human bronchial asthma. Pharmacologic studies have determined that cysteinyl leukotrienes activate at least 2 receptors, CysLTR1 and CysLTR2. Both receptors are members of the superfamily of G protein-coupled receptors. Activation of CysLTR1 by LTD4 results in contraction and proliferation of smooth muscle, oedema, eosinophil migration and damage to the mucus layer in the lung.
Potent CysLT1 (LTD4) inverse agonist. Also MRP1 inhibitor
| Alternate Names: | L-660711 |
| Chemical Name: | 3-[[[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propanoic acid |
| Purity: | ≥98% (HPLC) |
